Keisha Dyer, M.D.
NPI 1467666388 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · Orlando, FL
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1467666388
- Entity type
- Individual
- Primary specialty
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- A100110 (CA)
Specialties & taxonomies
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary207VF0040XLicense ME157180 (FL)
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,261 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 267 | $124 |
| Pelvic Exam99459 | 263 | $21 |
| Insertion of Temporary Bladder Tube51701 | 149 | $43 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 75 | $175 |
| Diagnostic Exam of Bladder and Urethra Using an Endoscope52000 | 71 | $227 |
| Complex Measurement of Pressure of Urine Flow in Bladder With Voiding Pressure Studies51728 | 70 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 461 | 277 |
| Vibegronbrand: Gemtesa | 141 | 50 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 118 | 85 |
| Trospium Chloride | 104 | 42 |
| Mirabegronbrand: Myrbetriq | 49 | 14 |
| Metronidazole | 33 | 23 |
| Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim | 28 | 25 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$288 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-05-09
- Last updated
- 2022-10-06
- Certified
- 2022-10-06
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.